Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neeraj Gupta

Showing results (301-310 of 353) with videos related to

Pageof 36
Sort By:
Clinical Pharmacology and Therapeutics|November 12, 2019
Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and DevelopmentNeeraj Gupta, Dean Bottino, Ulrika S H Simonsson, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community VisionJackson Burton, Bilal Abuasal, Sagar Bachhav, et al.
Clinical and Translational Science|January 18, 2022
Population pharmacokinetic and exposure-response analyses from ALTA-1L: Model-based analyses supporting the brigatinib dose in ALK-positive NSCLCNeeraj Gupta, Karen L Reckamp, David R Camidge, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Journal of Molecular Modeling|September 18, 2012
Molecular docking and dynamics simulations of A.niger RNase from Aspergillus niger ATCC26550: for potential prevention of human cancerGundampati Ravi Kumar, Rajasekhar Chikati, Santhi Latha Pandrangi, et al.
Indian Pediatrics|May 4, 2021
Impact of Air Pollution on Allergic Rhinitis and Asthma: Consensus Statement by Indian Academy of PediatricsK R Bharath Kumar Reddy, Neeraj Gupta, Barnali G Bhattacharya, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2018
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myelomaMeletios A Dimopoulos, Sebastian Grosicki, Wiesław W Jędrzejczak, et al.
The World Allergy Organization Journal|July 8, 2024
Understanding the burden of food allergy among urban and rural school children from north IndiaShruti Sehgal, Neeraj Gupta, Priyanka Dadha, et al.
British Journal of Haematology|November 22, 2018
Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myelomaShaji K Kumar, Norbert Grzasko, Sosana Delimpasi, et al.
Pageof 36

Showing results (301-310 of 353) with videos related to

Sort By:
Pageof 36
Clinical Pharmacology and Therapeutics|November 12, 2019
Transforming Translation Through Quantitative Pharmacology for High-Impact Decision Making in Drug Discovery and DevelopmentNeeraj Gupta, Dean Bottino, Ulrika S H Simonsson, et al.
Clinical Pharmacology and Therapeutics|June 12, 2023
Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community VisionJackson Burton, Bilal Abuasal, Sagar Bachhav, et al.
Clinical and Translational Science|January 18, 2022
Population pharmacokinetic and exposure-response analyses from ALTA-1L: Model-based analyses supporting the brigatinib dose in ALK-positive NSCLCNeeraj Gupta, Karen L Reckamp, David R Camidge, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Journal of Molecular Modeling|September 18, 2012
Molecular docking and dynamics simulations of A.niger RNase from Aspergillus niger ATCC26550: for potential prevention of human cancerGundampati Ravi Kumar, Rajasekhar Chikati, Santhi Latha Pandrangi, et al.
Indian Pediatrics|May 4, 2021
Impact of Air Pollution on Allergic Rhinitis and Asthma: Consensus Statement by Indian Academy of PediatricsK R Bharath Kumar Reddy, Neeraj Gupta, Barnali G Bhattacharya, et al.
European Journal of Cancer (Oxford, England : 1990)|November 25, 2018
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myelomaMeletios A Dimopoulos, Sebastian Grosicki, Wiesław W Jędrzejczak, et al.
The World Allergy Organization Journal|July 8, 2024
Understanding the burden of food allergy among urban and rural school children from north IndiaShruti Sehgal, Neeraj Gupta, Priyanka Dadha, et al.
British Journal of Haematology|November 22, 2018
Phase 2 study of all-oral ixazomib, cyclophosphamide and low-dose dexamethasone for relapsed/refractory multiple myelomaShaji K Kumar, Norbert Grzasko, Sosana Delimpasi, et al.
Pageof 36